Insulinotrophic and hypolipidemic effects of Ecklonia cava in streptozotocin-induced diabetic mice

Asian Pacific Journal of Tropical Medicine

Volumn 5, Issue 5, 2012, Pages 374-379

  Kim, Mi Ja ^a   Kim, Hye Kyung ^b  

^a Hanseo University   (South Korea)

^b Kyung Hee University Hospital   (South Korea)

Author keywords

Diabetes; Insulin; Lipid profile; Pancreatic cell; Streptozotocin

Indexed keywords

ALGAL EXTRACT; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; CHOLESTEROL; ECKLONIA CAVA EXTRACT; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; BROWN ALGA; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG SCREENING; DRUG SYNTHESIS; ECKLONIA CAVA; FATTY LIVER; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HISTOPATHOLOGY; HYPOLIPIDEMIC ACTIVITY; IN VITRO STUDY; INSULIN BLOOD LEVEL; INSULIN LIKE ACTIVITY; INSULIN RELEASE; LIVER EXAMINATION; MALE; MOUSE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; STREPTOZOCIN DIABETES;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; FATTY LIVER; GLUCOSE TOLERANCE TEST; HYPOGLYCEMIC AGENTS; HYPOLIPIDEMIC AGENTS; INSULIN; INSULIN-SECRETING CELLS; LIPID METABOLISM; MALE; MICE; PHYTOTHERAPY; SEAWEED;

EID: 84860358423     PISSN: 19957645     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1995-7645(12)60062-5     Document Type: Article

References (36)

1. Leonardi O, Mints G, Hussain MA Beta-cell apoptosis in the pathogenesis of human type 2 diabetes mellitus. Eur J Endocrinol 2003, 149:99-102.
2. Yki-Jarvinen H Glucose toxicity. Endocrine Rev 1992, 13:415-431.
3. Bonner-Weir S Life and death of the pancreatic beta cells. Trends Endocrinol Metab 2000, 11:375-378.
4. Reaven GM Role of insulin resistance in human diseases. Diabetes 1988, 37:1595-1607.
5. Brown WV Lipoprotein disorders in diabetes mellitus. Med Clin North Am 1994, 78:143-161.
6. Shin HC, Hwang HJ, Kang KJ, Lee BH An antioxidative and antiinflammatory agent for potential treatment of osteoarthritis from Ecklonia cava. Arch Pharm Res 2006, 29:165-171.
7. Kang HS, Chung HY, Kim JY, Son BW, Jung HA, Choi JS Inhibitory phlorotannins from the edible brown alga Ecklonia stolonifera on total reactive oxygen species (ROS) generation. Arch Pharm Res 2004, 27:194-198.
8. Ahn G, Hwang I, Park E, Kim J, Jeon YJ, Lee J, et al. Immunomodulatory effects of an enzymatic extract from Ecklonia cava on murine splenocytes. Mar Biotechnol (NY) 2008, 10:278-289.
9. Athukorala Y, Kim KN, Jeon YJ Antiproliferative and antioxidant properties of an enzymatic hydrolysate from brown alga, Ecklonia cava. Food Chem Toxicol 2006, 44:1065-1074.
10. Lee JH, Oh HY, Choi JS Preventive effect of Ecklonia stolonifera on the frequency of benzo(a)pyrene-induced chromosomal aberrations. J Food Sci Nutr 1996, 1:64-68.
11. Lee SH, Park MH, Heo SJ, Kang SM, Ko SC, Han JS, et al. Dieckol isolated from Ecklonia cava inhibits alpha-glucosidase and alpha-amylase in vitro and alleviates postprandial hyperglycemia in streptozotocin-induced diabetic mice. Food Chem Toxicol 2010, 48:2633-2637.
12. Friedwald WT, Levy RI, Fredrickson DS Estimation of low density lipoprotein cholesterol in plasma, without use of preparative ultracentrifugation. Clin Chem 1972, 18:499-502.
13. Folch J, Lees M, Sloan-Stanley GH A simple method for isolation and purification of total lipids from animal tissues. J Biol Chem 1957, 226:497-509.
14. Lacy PE, Kostianovsky M Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 1967, 16:35-39.
15. Ndong M, Uehara M, Katsumata S, Suzuki K Effects of oral administration of Moringa oleifera Lam on glucose tolerance in goto-kakizaki and wistar rats. J Clin Biochem Nutr 2007, 40:229-233.
16. Sathishsekar D, Subramanian S Beneficial effects of Momordica charantia seeds in the treatment of STZ-induced diabetes in experimental rats. Biol Pharm Bull 2005, 28:978-983.
17. Zhang L, Yang J, Chen XQ, Zan K, Wen XD, Chen H, et al. Antidiabetic and antioxidant effects of extracts from Potentilla discolor Bunge on diabetic rats induced by high fat diet and streptozotocin. J Ethnopharmacol 2010, 132:518-524.
18. Goldberg IJ Diabetic dyslipidemia: causes and consequences. J Clin Endocrinol Metab 2001, 86:965-971.
19. Taskinen MR Lipoprotein lipase in diabetes. Diabetes Metab Rev 1987, 3:551-570.
20. Niemeijer-Kanters SD, Banga JD, Erkelens DW Lipid-lowering therapy in diabetes mellitus. Neth J Med 2001, 58:214-222.
21. Saravanan R, Pari L Antihyperlipidemic and antiperoxidative effect of Diasulin, a polyherbal formulation in alloxan induced hyperglycemic rats. BMC Complement Altern Med 2005, 22:14-21.
22. Kannel WB Lipids, diabetes, and coronary heart disease: insights from the Framingham study. Am Heart J 1985, 110:1100-1107.
23. Garber AJ Attenuating CV risk factors in patients with diabetes: clinical evidence to clinical practice. Diabetes Obes Metab 2002, 4(Suppl 1):S5-S12.
24. Bainton D, Miller NE, Bolton CH, Yarnell JW, Sweetnam PM, Baker IA, et al. Plasma triglyceride and high density lipoprotein cholesterol as predictors of ischaemic heart disease in British men. The Caerphilly and Speedwell collaborative heart disease studies. Br Heart J 1992, 68:60-66.
25. El-Hazmi MA, Warsy AS Evaluation of serum cholesterol and triglyceride levels in 1-6-year-old Saudi children. J Trop Pediatr 2001, 47:181-185.
26. Markku L Epidemiology of diabetic dyslipidemia. Diabetes Rev 1995, 3:408-422.
27. Ramachandran S, Rajasekaran A, Manisenthilkumar KT Investigation of hypoglycemic, hypolipidemic and antioxidant activities of aqueous extract of Terminalia paniculata bark in diabetic rats. Asian Pac J Trop Biomed 2012, 2(4):262-268.
28. Balamurugan R, Ignacimuthu S Antidiabetic and hypolipidemic effect of methanol extract of Lippia nodiflora L. in streptozotocin induced diabetic rats. Asian Pac J Trop Biomed 2011, 1(Suppl 1):S30-S36.
29. Idogun ES, Kasia BE Assessment of microalbuminuria and glycated hemoglobin in type 2 diabetes mellitus complications. Asian Pac J Trop Dis 2011, 1(3):203-205.
30. Patel DK, Kumar R, Prasad SK, Sairam K, Hemalatha S Antidiabetic and in vitro antioxidant potential of Hybanthus enneaspermus (Linn) F. Muell in streptozotocin-induced diabetic rats. Asian Pac J Trop Biomed 2011, 1(4):316-322.
31. Oyedemi SO, Adewusi EA, Aiyegoro OA, Akinpelu DA Antidiabetic and haematological effect of aqueous extract of stem bark of Afzelia africana (Smith) on streptozotocin-induced diabetic Wistar rats. Asian Pac J Trop Biomed 2011, 1(5):353-358.
32. Girija K, Lakshman K, Udaya C, Sachi GS, Divya T Anti-diabetic and anti-cholesterolemic activity of methanol extracts of three species of Amaranthus. Asian Pac J Trop Biomed 2011, 1(2):133-138.
33. Day CP Pathogenesis of steatohepatitis. Best Pract Res Clin Gastroenterol 2002, 16:663-678.
34. Kang C, Jin YB, Lee H, Cha M, Sohn ET, Moon J, et al. Brown alga Ecklonia cava attenuates type 1 diabetes by activating AMPK and Akt signaling pathways. Food Chem Toxicol 2010, 48:509-516.
35. Ohno T, Kato N, Ishii C, Shimizu M, Ito Y, Tomono S, et al. Genistein augments cyclic adenosine 3'5'-monophosphate(cAMP) accumulation and insulin release in MIN6 cells. Endoc Res 1993, 19:273-285.
36. Noh JS, Kim HY, Park CH, Fujii H, Yokozawa T Hypolipidaemic and antioxidative effects of oligonol, a low-molecular-weight polyphenol derived from lychee fruit, on renal damage in type 2 diabetic mice. Br J Nutr 2010, 104:1120-1128.